Received Mar 14, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| HPV9 | HPV (GARDASIL 9) | MERCK & CO. INC. | 1 | — | — |
| HPV9 | HPV (GARDASIL 9) | MERCK & CO. INC. | 2 | — | — |
fainting; debilitate; vein disorders with many broken blood vessels; vein disorders; depressed; POTS syndrome/dizziness/nausea/vomiting/headache/dizzy/nauseous; chronic fatigue; Petechiae; joint pain; stomach ache; low heart rate; decline in health; er daughter received first dose of GARDAIL 9 on 2019 and second dose on 2021.; This spontaneous report was received from a consumer or other non health professional (patient's mother) via email and refers to a(n) 20-year-old female patient. The patient's medical history was not reported. The patient's concurrent conditions were not reported. Concomitant therapies were not reported. In 2019, the patient received first dose of Human Papillomavirus 9-valent Vaccine, Recombinant (GARDASIL®9), administered for vaccination (strength, dose, route of administration, lot # and expiration date were not reported). In 2021, the patient received second dose of Human Papillomavirus 9-valent Vaccine, Recombinant (GARDASIL®9), administered for vaccination (strength, dose, route of administration, lot # and expiration date were not reported) (Inappropriate schedule of product administration). She did not receive the third dose. Patient's mother only remembered consenting to one vaccine but apparently the patient received two doses. The patient was sick from receiving Human Papillomavirus 9-valent Vaccine, Recombinant (GARDASIL®9) from the pediatrician. Patient's mother was outraged about this. It was reported that the vaccine has debilitated the patient. Patient's mother had records for years on these symptoms since getting the vaccine. It was disgusting to have to go through this as a parent and watch the patient decline in health and doctors told the patient that all labs all tests were normal yet there were clear symptoms: she had been chronically fatigued, dizzy/dizziness, nauseous/nausea, vomiting, fainted/fainting, petechiae and vein disorders with many broken blood vessels, joint pain, stomach ache, headaches and low heart rate. The patient was still having those symptoms but not as severe. Patient's mother answered Yes to "Intervention to Prevent Serious Criteria" question because when her daughter fainted, they had to give her oxygen and answered Yes to "Significant Disability or Incapacity" because her daughter could not move normally because of severe chronic fatigue. Before the vaccination, the patient was very energetic but now she was so fatigue that she applied for disability benefit. The patient was depressed and see a psychologist and she could be depressed from her physical symptoms that have taken over. The patient was being a top athlete and just going down hill because she had Postural orthostatic tachycardia syndrome (POTS) syndrome but the reporter wondered where did that come from and requested company to explain this which many people have reported the same symptoms. Patient's mother mentioned attorney because she decided to join the class action lawsuit against Human Papillomavirus 9-valent Vaccine, Recombinant (GARDASIL®9). Blood tests and ultrasound were performed but no results provided. No additional adverse events (AEs) were reported, no further information provided. At the time of reporting, the outcome of all events was reported as not recovered. The causality relationship between all events and suspect vaccine was considered as related. The reporter considered the event of fainting to be medically significant. The reporter considered the event of chronic fatigue to be disabling/incapacitating. Lot is being requested and will be submitted if received.
Test Name: tests; Result Unstructured Data: all labs all tests were normal